| Website | frazierhealthcare... |
| Phone | 206.621.7200 |
| Employees | |
| Founded | 1991 |
| Frazier Healthcare VII LP, 5/13 | $282M |
Founded in 1991, Frazier Healthcare Ventures is one of the leading providers of venture and growth equity capital to emerging biopharma, medical device and healthcare service companies. With over $1.8 billion under management, Frazier Healthcare has invested in over 100 companies across the entire developmental spectrum. From seed stage venture investments to leveraged recapitalizations of cash generating companies, Frazier Healthcare Ventures has established itself among entrepreneurs and seasoned executives as the preferred partner to grow successful healthcare companies.
| Company | Date | Round | Size | Participants |
| Glaukos | 2/13 | Series F | $30M | 7 |
| Atterocor | 8/12 | Series A | $16M | 2 |
| Alcresta | 4/12 | Series A | $10M | 3 |
| Allena Pharmaceuticals | 11/11 | Series A | $15M | 3 |
| Rempex Pharmaceuticals | 11/11 | Series B | $67.5M | 5 |
| PowerVision | 7/11 | Series C | $24M | 5 |
| Chimerix | 2/11 | Series F | $45M | 8 |
| Tobira Therapeutics | 9/10 | Series B | $31M | 5 |
| Nuon Therapeutics | 8/10 | Venture Round | $10M | 3 |
| BARRX Medical | 7/10 | Series D | $15M | 6 |
| Calistoga Pharmaceuticals | 6/10 | Series C | $40M | 6 |
| Incline Therapeutics | 6/10 | Series A | $43M | 6 |
| Zeltiq Aesthetics | 6/10 | Series D | $25M | 4 |
| Achaogen | 4/10 | Series C | $56M | 7 |
| Nuon Therapeutics | 3/10 | Venture Round | $6.05M | 3 |
| VentiRx Pharmaceuticals | 1/10 | Series A | $51.6M | 4 |
| Calibra Medical | 11/09 | Venture Round | $1.4M | 5 |
| Calypso Medical | 11/09 | Series E | $50M | 4 |
| Barosense | 8/09 | Series D | $27M | 7 |
| Clovis Oncology | 5/09 | Series A | $145M | 7 |
| Calistoga Pharmaceuticals | 5/09 | Series B | $30M | 4 |
| Stemgent | 3/09 | Series B | $14M | 2 |
| Primaeva Medical | 2/09 | Series C | $6M | 3 |
| Intradigm Corporation | 1/09 | Series B | $21.4M | 8 |
| Alnara Pharmaceuticals | 10/08 | Series A | $20M | 3 |
| Glaukos | 8/08 | Series D | $35M | 7 |
| PatientKeeper | 8/08 | Series F | $7.5M | 3 |
| EBR Systems | 6/08 | Series C | $35M | 5 |
| Nuon Therapeutics | 4/08 | Series B | $27M | 2 |
| Stromedix | 4/08 | Series B | $25M | 5 |
| Zonare Medical Systems | 2/08 | Venture Round | $30M | 8 |
| PowerVision | 12/07 | Series B | $20M | 3 |
| AnaptysBio | 11/07 | Series B | $33M | 6 |
| Zeltiq Aesthetics | 10/07 | Series B | $20.3M | 2 |
| FlowCardia | 8/07 | Series C | $30M | 9 |
| Marcadia Biotech | 5/07 | Series A | $15M | 3 |
| Stromedix | 3/07 | Series A | $1M | 2 |
| Calistoga Pharmaceuticals | 3/07 | Series A | $21M | 4 |
| Chimerix | 2/07 | Series D | $23.1M | 4 |
| Primaeva Medical | 12/06 | Series B | $7M | 2 |
| Intradigm Corporation | 11/06 | Series A | $16M | 5 |
| PatientKeeper | 6/06 | Venture Round | $8M | 7 |
| Juniper Medical | 3/06 | Series A | $7.5M | 2 |
| Primaeva Medical | 2006 | Series A | $1.25M | 2 |
| EBR Systems | 10/05 | Venture Round | $21M | 4 |
| Glaukos | 9/02 | Series A | $10M | 3 |
